Catalyst Wire Dossier Catalyst Wire Dossier

EMB-001

Metyrapone/Oxazepam combination · Embera NeuroTherapeutics, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for EMB-001, covering 2016-07-22 to 2023-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder [Phase 2]

See pricing